title: Esophageal lymphangiomatosis: a case report.
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
authors.forename: Bo-In
authors.initials: BI
authors.lastname: Lee
authors.forename: Byung-Wook
authors.initials: BW
authors.lastname: Kim
authors.forename: Kyoung-Mee
authors.initials: KM
authors.lastname: Kim
authors.forename: Ho-Jin
authors.initials: HJ
authors.lastname: Song
authors.forename: Se-Hyun
authors.initials: SH
authors.lastname: Cho
authors.forename: Hwang
authors.initials: H
authors.lastname: Choi
authors.forename: Myung-Gyu
authors.initials: MG
authors.lastname: Choi
authors.forename: Kyu-Yong
authors.initials: KY
authors.lastname: Choi
authors.forename: In-Sik
authors.initials: IS
authors.lastname: Chung
authors.forename: Sang-Bok
authors.initials: SB
authors.lastname: Cha
authors.forename: Hee-Sik
authors.initials: HS
authors.lastname: Sun
authors.forename: Doo-Ho
authors.initials: DH
authors.lastname: Park
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D019160:Endosonography; D004934:Esophageal Cyst / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D004945:Esophagoscopy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D008202:Lymphangioma / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D008297:Male; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins